Market Cap 697.28M
Revenue (ttm) 891.97M
Net Income (ttm) -117.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -13.13%
Debt to Equity Ratio 0.71
Volume 21,800
Avg Vol 58,436
Day's Range N/A - N/A
Shares Out 355.76M
Stochastic %K 6%
Beta 1.96
Analysts Sell
Price Target $2.80

Company Profile

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic diseases, and rare diseases. It is...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 49 40 560 81 0
Address:
Essener Bogen 7, Hamburg, Germany
Lane0507
Lane0507 Aug. 4 at 11:31 PM
$EVO -The company has collaborations with leading drug makers, providing milestone payments, research funding and potential royalties if partnered drugs succeed..
0 · Reply
MarketIntel_
MarketIntel_ Jul. 16 at 12:58 PM
$EVO This is exactly why patience matters in trading. A lot of people want to jump in the moment a setup appears, but confirmation is everything. If you bought right when the previous post came out, you’d already be sitting on a ~30% loss within days. The chart is still showing weakness, and price action continues to suggest there may be more downside ahead. Good trades are not about catching every move. They’re about waiting for the right moment, protecting capital, and letting the chart prove the setup before taking a position.
0 · Reply
Merlintrader
Merlintrader Jul. 14 at 12:02 PM
$BIIB Biotech Radar July 14, 2026: Biogen, AstraZeneca, GSK and Evotec — $BIIB, $AZN, $GSK, $EVO https://www.merlintrader.com/biotech-radar-july14-2026/
0 · Reply
BillionerOfKing
BillionerOfKing Jul. 8 at 6:00 PM
$EVO Current Stock Price: $2.76
0 · Reply
AlexeiMoro
AlexeiMoro Jun. 17 at 8:56 PM
$EVO around 11–12x earnings, which is unusually low for a company that still generates extremely high margins and strong cash flow..,
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 9 at 8:57 PM
0 · Reply
peloswing
peloswing May. 13 at 1:27 PM
$EVO -12% in pre-market following €116.1 Million Convertible Bond headline 🔻
0 · Reply
KOWALSK1
KOWALSK1 Apr. 20 at 6:56 PM
0 · Reply
AnonMav
AnonMav Apr. 17 at 3:11 PM
$EVO Reclaim story begins
0 · Reply
KOWALSK1
KOWALSK1 Apr. 16 at 10:50 PM
0 · Reply
Latest News on EVO
Evotec SE Quarterly report: Q2 2026

Aug 13, 2026, 6:00 AM EDT - 6 days ago

Evotec SE Quarterly report: Q2 2026


Evotec enters R&D collaboration with Odyssey Therapeutics

2026-08-06T09:20:26.000Z - 13 days ago

Evotec enters R&D collaboration with Odyssey Therapeutics

ODTX


Evotec SE Slides: Company presentation

Aug 1, 2026, 8:00 AM EDT - 18 days ago

Evotec SE Slides: Company presentation


Evotec downgraded to Hold from Buy at Berenberg

2026-07-16T08:15:10.000Z - 4 weeks ago

Evotec downgraded to Hold from Buy at Berenberg


Evotec price target lowered to $2.40 from $3 at BofA

2026-07-15T13:45:51.000Z - 4 weeks ago

Evotec price target lowered to $2.40 from $3 at BofA


Evotec price target lowered to $4 from $7 at H.C. Wainwright

2026-07-15T10:00:22.000Z - 5 weeks ago

Evotec price target lowered to $4 from $7 at H.C. Wainwright


Evotec downgraded to Hold from Buy at TD Cowen

2026-07-15T01:55:10.000Z - 5 weeks ago

Evotec downgraded to Hold from Buy at TD Cowen


Evotec Q2 Earnings Call Highlights

Tue, 14 Jul 2026 09:03:38 -0400 - 5 weeks ago

Evotec Q2 Earnings Call Highlights


Evotec SE Earnings Call Transcript: Q2 2026

Jul 14, 2026, 8:00 AM EDT - 5 weeks ago

Evotec SE Earnings Call Transcript: Q2 2026


Evotec SE Earnings release: Q2 2026

Jul 14, 2026, 8:00 AM EDT - 5 weeks ago

Evotec SE Earnings release: Q2 2026


Evotec SE Slides: Q2 2026

Jul 14, 2026, 8:00 AM EDT - 5 weeks ago

Evotec SE Slides: Q2 2026


Evotec expands biologics services with J.TRAIN

2026-06-30T09:30:24.000Z - 7 weeks ago

Evotec expands biologics services with J.TRAIN


Evotec SE Proxy statement: Proxy filing

Jun 23, 2026, 8:00 AM EDT - 2 months ago

Evotec SE Proxy statement: Proxy filing


Evotec SE Slides: Company presentation

Jun 17, 2026, 1:00 AM EDT - 2 months ago

Evotec SE Slides: Company presentation


Evotec Reports Results of the Annual General Meeting 2026

Jun 11, 2026, 12:02 PM EDT - 2 months ago

Evotec Reports Results of the Annual General Meeting 2026

EVO


Evotec Appoints Rui Wang as Head of Global In Silico and AI

Jun 2, 2026, 1:45 AM EDT - 2 months ago

Evotec Appoints Rui Wang as Head of Global In Silico and AI

EVO


Evotec Receives Grants to Advance Tuberculosis Treatment

Apr 30, 2026, 3:20 AM EDT - 3 months ago

Evotec Receives Grants to Advance Tuberculosis Treatment

EVO


Evotec Announces New Nomination to Board of Directors

Apr 29, 2026, 4:45 PM EDT - 3 months ago

Evotec Announces New Nomination to Board of Directors

EVO


Evotec SE to Announce First Quarter 2026 Results on May 6, 2026

Apr 29, 2026, 1:50 AM EDT - 4 months ago

Evotec SE to Announce First Quarter 2026 Results on May 6, 2026

EVO


Evotec Announces Chief Financial Officer Transition

Apr 24, 2026, 1:50 AM EDT - 4 months ago

Evotec Announces Chief Financial Officer Transition

EVO


Evotec assumed with a Buy at H.C. Wainwright

2026-04-15T10:15:24.000Z - 4 months ago

Evotec assumed with a Buy at H.C. Wainwright


Evotec appoints Ingrid Muller as COO

2026-04-15T09:20:59.000Z - 4 months ago

Evotec appoints Ingrid Muller as COO


Evotec Appoints Dr. Ingrid Müller as Chief Operating Officer

Apr 15, 2026, 1:50 AM EDT - 4 months ago

Evotec Appoints Dr. Ingrid Müller as Chief Operating Officer

EVO


Evotec SE Earnings Call Transcript: Q4 2025

Apr 8, 2026, 8:00 AM EDT - 4 months ago

Evotec SE Earnings Call Transcript: Q4 2025


Evotec Nominates Dieter Weinand as Supervisory Board Chairman

Apr 7, 2026, 3:00 AM EDT - 4 months ago

Evotec Nominates Dieter Weinand as Supervisory Board Chairman

EVO


Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer

Apr 1, 2026, 1:50 AM EDT - 5 months ago

Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer

EVO


Evotec initiated with a Buy at Berenberg

2026-02-03T09:25:11.000Z - 7 months ago

Evotec initiated with a Buy at Berenberg


Evotec announces up to EUR 3M share repurchase program

2025-11-06T14:46:32.000Z - 10 months ago

Evotec announces up to EUR 3M share repurchase program


Evotec SE Earnings Call Transcript: Q1 2025

May 6, 2025, 8:00 AM EDT - 1 year ago

Evotec SE Earnings Call Transcript: Q1 2025


Evotec Announces Change in Management Board

Feb 26, 2025, 2:00 AM EST - 1 year ago

Evotec Announces Change in Management Board

EVO


Comment on Withdrawn Non-Binding Offer

Nov 22, 2024, 11:15 AM EST - 1 year ago

Comment on Withdrawn Non-Binding Offer

EVO


Halozyme withdraws $2.1 bln buyout offer for Evotec

Nov 22, 2024, 8:55 AM EST - 1 year ago

Halozyme withdraws $2.1 bln buyout offer for Evotec

EVO HALO


Lane0507
Lane0507 Aug. 4 at 11:31 PM
$EVO -The company has collaborations with leading drug makers, providing milestone payments, research funding and potential royalties if partnered drugs succeed..
0 · Reply
MarketIntel_
MarketIntel_ Jul. 16 at 12:58 PM
$EVO This is exactly why patience matters in trading. A lot of people want to jump in the moment a setup appears, but confirmation is everything. If you bought right when the previous post came out, you’d already be sitting on a ~30% loss within days. The chart is still showing weakness, and price action continues to suggest there may be more downside ahead. Good trades are not about catching every move. They’re about waiting for the right moment, protecting capital, and letting the chart prove the setup before taking a position.
0 · Reply
Merlintrader
Merlintrader Jul. 14 at 12:02 PM
$BIIB Biotech Radar July 14, 2026: Biogen, AstraZeneca, GSK and Evotec — $BIIB, $AZN, $GSK, $EVO https://www.merlintrader.com/biotech-radar-july14-2026/
0 · Reply
BillionerOfKing
BillionerOfKing Jul. 8 at 6:00 PM
$EVO Current Stock Price: $2.76
0 · Reply
AlexeiMoro
AlexeiMoro Jun. 17 at 8:56 PM
$EVO around 11–12x earnings, which is unusually low for a company that still generates extremely high margins and strong cash flow..,
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 9 at 8:57 PM
0 · Reply
peloswing
peloswing May. 13 at 1:27 PM
$EVO -12% in pre-market following €116.1 Million Convertible Bond headline 🔻
0 · Reply
KOWALSK1
KOWALSK1 Apr. 20 at 6:56 PM
0 · Reply
AnonMav
AnonMav Apr. 17 at 3:11 PM
$EVO Reclaim story begins
0 · Reply
KOWALSK1
KOWALSK1 Apr. 16 at 10:50 PM
0 · Reply
BioTuesdays
BioTuesdays Apr. 15 at 2:53 PM
$EVO has appointed Dr. Ingrid Müller as Chief Operating Officer (COO), effective May 1, 2026. https://biotuesdays.com/2026/04/15/dr-ingrid-muller-joins-evotec-as-coo/
0 · Reply
LewisDaKat
LewisDaKat Apr. 15 at 10:31 AM
$EVO Evotec Appoints Dr. Ingrid M ller as Chief Operating Officer https://marketwirenews.com/stock/evo/news/evotec-appoints-dr-ingrid-m-xfc-ller-as-chief-operat-6497978197933043.html?utm_source=stocktwits
0 · Reply
AnonMav
AnonMav Apr. 14 at 9:56 AM
$EVO 1st sign of life 👍
0 · Reply
AnonMav
AnonMav Apr. 12 at 1:47 AM
$EVO Six levels painted. You're at the bottom of the structure, grinding on purple. Below $2.52 = pain. Above $2.95 = first sign of life. Everything above $3.28 is a reclaim story. Don't hold your breath but keep it on the radar. 🤙 https://share.trendspider.com/chart/EVO/94993v3s3vk?_go=anonmav
0 · Reply
investmentstarry
investmentstarry Apr. 2 at 8:45 AM
$EVO — Capital Allocation Update 💡 Board proposes ZERO dividend for 2025 Company pivoting toward share buybacks I like this move — better capital allocation while valuation remains low (PE ~10x)
0 · Reply
BioTuesdays
BioTuesdays Apr. 1 at 2:55 PM
$EVO has appointed Dr. Ashiq H. Khan as EVP global head, chief commercial officer (CCO). https://biotuesdays.com/2026/04/01/evotec-appoints-dr-ashiq-h-khan-as-cco/
0 · Reply
KOWALSK1
KOWALSK1 Mar. 24 at 11:54 AM
$EVO Evotec ag ✅️ BUY ZONE 2.39 to 2.38 ✋️ RISK BELOW 2.21 🎯 PT. 2.50 2.59 2.70 2.97 3.12 + UP Follow for more
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 16 at 6:41 PM
$EVO Current Stock Price: $3.52
0 · Reply